What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Cancer
Internal medicine, Cardiology, Heart failure, Endocrinology and Heart disease are his primary areas of study.
As a part of the same scientific study, Joshua M. Hare usually deals with the Internal medicine, concentrating on Surgery and frequently concerns with Incidence.
His Cardiology study integrates concerns from other disciplines, such as Randomized controlled trial and Hazard ratio.
His Heart failure research integrates issues from Anesthesia and Pulmonary artery.
His work is dedicated to discovering how Endocrinology, Xanthine oxidase are connected with Reactive oxygen species and Circulatory system and other disciplines.
His Heart disease research includes themes of Pathophysiology and Heart rate.
His most cited work include:
- FGF23 induces left ventricular hypertrophy (1321 citations)
- Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. (1223 citations)
- A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study of Intravenous Adult Human Mesenchymal Stem Cells (Prochymal) After Acute Myocardial Infarction (1094 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Internal medicine, Cardiology, Stem cell, Heart failure and Mesenchymal stem cell.
In his research on the topic of Internal medicine, Receptor is strongly related with Endocrinology.
The Cardiology study combines topics in areas such as Surgery, Transplantation and Diastole.
His studies in Heart failure integrate themes in fields like Xanthine oxidase and Heart disease.
He interconnects Cancer research, Clinical trial and Bone marrow in the investigation of issues within Mesenchymal stem cell.
His Nitric oxide research includes elements of Reactive oxygen species and Biochemistry.
He most often published in these fields:
- Internal medicine (50.98%)
- Cardiology (27.75%)
- Stem cell (24.89%)
What were the highlights of his more recent work (between 2016-2021)?
- Internal medicine (50.98%)
- Stem cell (24.89%)
- Mesenchymal stem cell (22.93%)
In recent papers he was focusing on the following fields of study:
His main research concerns Internal medicine, Stem cell, Mesenchymal stem cell, Cardiology and Heart failure.
His Internal medicine study combines topics from a wide range of disciplines, such as Endocrinology and Cell therapy.
The concepts of his Stem cell study are interwoven with issues in Transplantation, Hedgehog signalling, Kidney and Function.
His research in Mesenchymal stem cell focuses on subjects like Cancer research, which are connected to Prostate cancer, Nitric oxide and Carcinogenesis.
His study explores the link between Cardiology and topics such as Stem-cell therapy that cross with problems in Stroke, Cell and Heart disease.
Joshua M. Hare usually deals with Heart failure and limits it to topics linked to Clinical trial and Surgery and Placebo.
Between 2016 and 2021, his most popular works were:
- Mesenchymal stem cell perspective: cell biology to clinical progress (229 citations)
- Cardiomyocyte regeneration: A consensus statement (225 citations)
- Randomized Comparison of Allogeneic Versus Autologous Mesenchymal Stem Cells for Nonischemic Dilated Cardiomyopathy: POSEIDON-DCM Trial (151 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Cancer
Joshua M. Hare spends much of his time researching Internal medicine, Mesenchymal stem cell, Stem cell, Heart failure and Cardiology.
His Internal medicine course of study focuses on Endocrinology and Endothelial stem cell.
Joshua M. Hare has included themes like Progenitor cell, Stromal cell, Regenerative medicine and Paracrine signalling in his Mesenchymal stem cell study.
The various areas that Joshua M. Hare examines in his Stem cell study include Clinical trial, Podocyte, Transplantation and Homeostasis.
His research investigates the connection between Heart failure and topics such as Intensive care medicine that intersect with issues in Position paper and MEDLINE.
In Cardiology, Joshua M. Hare works on issues like Stem-cell therapy, which are connected to Cell and Ischemia.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
